PARP and PARG inhibitors in cancer treatment - Slade, Dea (Genes & development, 2020)
Keywords: Antineoplastic Agents - therapeutic use; Genomic Instability; Glycoside Hydrolases - antagonists & inhibitors; Glycoside Hydrolases - metabolism; Humans; Neoplasms - drug therapy; Neoplasms - enzymology; Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use; Poly(ADP-ribose) Polymerases - metabolism; Special Section: Review; poly(ADP-ribose) polymerases; cancer therapy; poly(ADP-ribose) glycohydrolase; PARG inhibitor; PARP inhibitor